Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib-Reference-Cited by-同舟云学术

Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib

Published:2015-05-13 Issue:5 Volume:10 Page:e0125232
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bessette Darrell C.,Tilch Erik,Seidens Tatjana,Quinn Michael C. J.,Wiegmans Adrian P.,Shi Wei,Cocciardi Sibylle,McCart-Reed Amy,Saunus Jodi M.,Simpson Peter T.,Grimmond Sean M.,Lakhani Sunil R.,Khanna Kum Kum,Waddell Nic,Al-Ejeh Fares,Chenevix-Trench Georgia

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference96 articles.

1. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;T Sorlie;Proc Natl Acad Sci U S A,2001

2. Comprehensive molecular portraits of human breast tumours;Nature,2012

3. Molecular portraits of human breast tumours;CM Perou;Nature,2000

4. Basal-like breast carcinomas: clinical outcome and response to chemotherapy;S Banerjee;J Clin Pathol,2006

5. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study;LA Carey;JAMA,2006

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitory potency of the nettle lectin on neovascularization: a biomolecule for carbohydrate-mediated targeting of angiogenesis;Molecular Biology Reports;2023-04-06

2. Convection and extracellular matrix binding control interstitial transport of extracellular vesicles;Journal of Extracellular Vesicles;2023-04

3. Inhibitory Potency of UDA Lectin on Neovascularization: A Biomolecule for Carbohydrate-Mediated Targeting of Angiogenesis;2022-12-19

4. Short-term PI3K Inhibition Prevents Breast Cancer in Preclinical Models;Cancer Prevention Research;2022-11-04

5. Genetic alterations shaping tumor response to anti-EGFR therapies;Drug Resistance Updates;2022-09